Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
1.3950
+0.0150 (1.09%)
Rani Therapeutics Holdings Inc. is a biopharmaceutical company focused on developing innovative oral therapies for the delivery of biologics, such as peptides and proteins, which traditionally require injection for administration
The company’s proprietary RaniPill platform utilizes a novel approach to encapsulate and deliver these treatments orally, aiming to enhance patient compliance and accessibility in the administration of complex medications. By combining advanced engineering with pharmaceutical expertise, Rani Therapeutics is exploring solutions that could revolutionize the landscape of therapeutic delivery, making it more patient-friendly.
Frequently Asked Questions
Is Rani Therapeutics Holdings, Inc. - Class A Common Stock publicly traded?
Yes, Rani Therapeutics Holdings, Inc. - Class A Common Stock is publicly traded.
What exchange does Rani Therapeutics Holdings, Inc. - Class A Common Stock trade on?
Rani Therapeutics Holdings, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rani Therapeutics Holdings, Inc. - Class A Common Stock?
The ticker symbol for Rani Therapeutics Holdings, Inc. - Class A Common Stock is RANI on the Nasdaq Stock Market
What is the current price of Rani Therapeutics Holdings, Inc. - Class A Common Stock?
The current price of Rani Therapeutics Holdings, Inc. - Class A Common Stock is 1.395
When was Rani Therapeutics Holdings, Inc. - Class A Common Stock last traded?
The last trade of Rani Therapeutics Holdings, Inc. - Class A Common Stock was at 2:36 pm EST on January 31st, 2025